Reviv3 Procare Company
RVIV · OTC
11/30/2025 | 8/31/2025 | 5/31/2025 | 2/28/2025 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.00 | 0.00 | -4.37 |
| FCF Yield | 0.00% | 0.00% | 0.00% | -0.26% |
| EV / EBITDA | 91.62 | -56.74 | 0.00 | 137.83 |
| Quality | ||||
| ROIC | 5.72% | 0.00% | 0.00% | 4.91% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | -0.29 | 0.96 | -1.17 | 0.84 |
| Growth | ||||
| Revenue 3-Year CAGR | -39.95% | -17.84% | 4.45% | 29.53% |
| Free Cash Flow Growth | 0.00% | 0.00% | 0.00% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | -4.95 | -56.74 | 0.00 | -6.67 |
| Interest Coverage | -692.54 | 0.00 | 0.00 | 458.78 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |